Njirimara arụmọrụ
Oke nchọpụta: 5ng/ml;
Oke Linear: 5.00 ~ 400.00 ng/ml;
Ọnụọgụ njikọ linear R ≥0.990;
Nkenkenke: n'ime ogbe CV bụ ≤15%;n'etiti batches CV bụ ≤20%;
Nzizi: ngbanwe nke nsonaazụ nha agaghị agafe ± 15% mgbe a nwalere calibrator ziri ezi.
1. Chekwaa ihe nchọta ihe na 2～30℃.Ihe nchekwa ahụ kwụsiri ike ruo ọnwa iri na asatọ.
2. Chekwaa cassette nke Aehealth Ferritin Rapid Quantitative na 2℃, ndụ shelf bụ ọnwa 18.
3. Ekwesịrị iji cassette ule mee ihe n'ime awa 1 mgbe imepechara mkpọ ahụ.
ST2 bụ onye otu Toll-like receptor/interleukin-1 (interleukin-1, IL-1) ezinụlọ nnata.IL-33 bụ ligand na-arụ ọrụ ya kpọmkwem ma na-ezobe ya site na cardiomyocytes na fibroblasts.Ngwaahịa abụọ nke mkpụrụ ndụ ihe nketa: transmembrane ST2 (ST2L) na sST2.ST2L nwere ngalaba immunoglobulin extracellular atọ, ebe sST2 enweghị ngalaba nnabata transmembrane na intracellular.Ha na-ejikọta na ligand nkịtị IL-33 ma na-arụ ọrụ ndu.Ụzọ mgbaàmà ST2L na IL-33 nwere mmetụta cardioprotective dị ka anti-cardiomyocyte hypertrophy, myocardial fibrosis na anti-atherosclerosis.Mgbe ibu obi na-abawanye, ihe nzuzo sST2 na-abawanye, na sST2 na-abawanye na-egbochi IL-33 site na ijikọta na ST2L, si otú ahụ na-eguzogide mmetụta cardioprotective nke IL-33 / ST2L akara ụzọ.A na-eche na sST2 nwere ike ịbụ onye ogbugbo nke cardiomyocyte hypertrophy na myocardial fibrosis.Mkpebi ọnụọgụgụ nke ọkwa sST2 nwere ike inye ndị dọkịta ngwa ọrụ ziri ezi iji nyere aka na nyocha nke nkụda obi.